• Dapps:16.23K
  • Blockchains:78
  • Active users:66.47M
  • 30d volume:$303.26B
  • 30d transactions:$879.24M

Apogee Enterprises: Fiscal 2025 Q3 Performance

user avatar

by Giorgi Kostiuk

a year ago


Apogee Enterprises has announced its fiscal 2025 Q3 results, showing varied performance across its business segments.

Quarterly Financial Summary

Apogee Enterprises recorded net sales of $341 million, marking a 0.5% increase from the previous year, driven primarily by the acquisition of UW Solutions, which contributed $8.8 million in sales.

Challenges and Achievements

Despite increased sales, Apogee faced challenges with a decline in operating income to $28.6 million, a drop of 24% from the previous year. The operating margin also decreased from 11.1% to 8.4%. The diluted earnings per share stood at $0.96, down from $1.23 in the previous year, but the adjusted diluted EPS was reported at $1.19, slightly surpassing last year's adjusted figure of $1.23.

Full-Year Outlook

Looking ahead, Apogee Enterprises forecasts a full-year net sales decline of about 5%, considering a $30 million contribution from the UW Solutions acquisition and lower-than-expected Q4 volume.

Apogee's Q3 results were mixed, with some areas outperforming expectations while others, such as profitability, underperformed. Going forward, the company remains focused on cost reduction and product line optimization.

0

Rewards

chest
chest
chest
chest

More rewards

Discover enhanced rewards on our social media.

chest

Other news

Beware of Scams in C2C Crypto Trading

chest

C2C trading exposes users to several common scams, including fake payment proofs and chargeback fraud. Traders must be vigilant and adopt security measures to protect their assets from these fraudulent tactics.

user avatarAyman Ben Youssef

Ethereum Trading Indicators Show Mixed Signals

chest

Current technical analysis of Ethereum reveals mixed signals, with the MACD indicating bearish momentum while the Chaikin Money Flow suggests strong buying pressure.

user avatarElias Mukuru

Knightsbridge Savings Announces Improved Investment Rates for 2026

chest

Knightsbridge Savings announces improved investment rates for 2026, offering enhanced options for both entry-level and high-end investors.

user avatarDiego Alvarez

Converge Bio's AI Platform Aims to Transform Drug Development

chest

Converge Bio is leveraging its newly acquired $25 million funding to enhance its AI platform, which focuses on drastically reducing the time and costs associated with drug development.

user avatarKenji Takahashi

Converge Bio Secures $25 Million Series A Funding to Transform Drug Discovery

chest

Converge Bio, a startup based in Boston and Tel Aviv, has raised $25 million in Series A funding to enhance AI-driven drug discovery.

user avatarMaria Fernandez

Buterin Continues Charity Donations from Token Sales

chest

Vitalik Buterin continues his practice of selling unsolicited tokens and donating the proceeds to charity, emphasizing ethical considerations in cryptocurrency promotions.

user avatarRajesh Kumar

Important disclaimer: The information presented on the Dapp.Expert portal is intended solely for informational purposes and does not constitute an investment recommendation or a guide to action in the field of cryptocurrencies. The Dapp.Expert team is not responsible for any potential losses or missed profits associated with the use of materials published on the site. Before making investment decisions in cryptocurrencies, we recommend consulting a qualified financial advisor.